Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05998005 · ClinicalTrials.gov registry record · NA
First Face Training Evaluation in Tribal Communities
A NA study of Substance-Related Disorders and Mental Health, sponsored by Cambridge Health Alliance.
- Recruiting
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 9
- Study locations
NCT05998005: Recruiting NA study of Substance-Related Disorders and Mental Health, sponsored by Cambridge Health Alliance.
NCT05998005 is a NA study of Substance-Related Disorders and Mental Health that is actively recruiting participants, run by Cambridge Health Alliance. The registered enrollment target is 1,000 participants, below the 1,504-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (34% lower). The trial reports 9 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05998005, a NA study of Substance-Related Disorders and Mental Health, is actively recruiting participants, sponsored by Cambridge Health Alliance.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 9
- Study locations
Study Summary
The goal of this study is to evaluate a culturally grounded training curriculum, First Face for Mental Health, in Tribal communities, using a waitlist controlled trial design. This curriculum will train Tribal community members in how to respond to youth and adults experiencing mental health crises and serve as a bridge between these individuals and the help they need. The main questions the study aims to answer are: * Does the training increase mental health knowledge, capacity and ability to respond to mental health situations, perceived competence to respond, and actual responsive actions among trainees? * Does the training decrease mental health stigmatizing attitudes and increase cultural identity among trainees? Participants will complete surveys before and after completing the First Face training, across five time points over the course of two years. Half of the participants will receive the training initially, and half will receive it six months later. Researchers will compare the two groups to examine whether the trainees demonstrate changes in the outcomes of interest compared to the waitlist control group during the first six months, and whether both groups demonstrate sustained changes after the first six months (i.e., once both groups have received training).
Primary Outcome
A novel 22-item summed index (possible range from 0 to 22) derived from the First Face Training course to measure knowledge about mental health. Each multiple choice question focuses on a different mental health knowledge item and has one correct answer. Each participant will receive 1 point for each correct answer and 0 points for each incorrect answer. Higher scores indicate a better outcome (i.e., more knowledge about mental health).
Conditions Studied
Interventions
- BEHAVIORAL First Face Training Program
Study Locations (9)
Washington
- Kalispel Tribe of Indians - Cusick
- Confederated Tribes of the Colville Reservation - Nespelem
- Healing Lodge of the Seven Nations - Spokane Valley
- Spokane Tribe of Indians - Wellpinit
Idaho
- Kootenai Tribe of Idaho - Bonners Ferry
- Nez Perce Tribe - Lapwai
- Coeur d'Alene Tribe - Plummer
Massachusetts
- Division on Addiction, Cambridge Health Alliance - Malden
Oregon
- Confederated Tribes of the Umatilla Indian Reservation - Pendleton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-08-30 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What NCT05998005 shows while recruiting
NCT05998005 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 1,504-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (34% lower).
The record links to 2 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which First Face Training Program is the first listed.
NCT05998005 lists 9 locations in 4 states (Washington, Idaho, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT05998005 about?
NCT05998005 is a clinical study titled "First Face Training Evaluation in Tribal Communities". The goal of this study is to evaluate a culturally grounded training curriculum, First Face for Mental Health, in Tribal communities, using a waitlist controlled trial design. This curriculum will train Tribal community members in how to respond to youth and adults experiencing mental health crises ...
What is the current status of trial NCT05998005?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2023-08-30. Estimated completion is 2026-06-01.
What conditions does trial NCT05998005 study?
This clinical trial studies the following conditions: Substance-Related Disorders, Mental Health.
What interventions are being tested in trial NCT05998005?
The interventions under investigation include: First Face Training Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05998005?
This trial is sponsored by Cambridge Health Alliance, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05998005 being conducted?
This trial has 9 study locations across Idaho, Massachusetts, Oregon, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05998005's enrollment target sits among peer trials
1,000 4th of 58 higher than 55 of 58 other Substance-Related Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families
RECRUITING · NA
-
Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions
RECRUITING · NA
-
Feasibility of the 5-Step Method in the U.S.
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
-
Expression of Stress Markers During Meth Treatment (EXPRESS+)
RECRUITING · NA
-
Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI